Global Immunotherapy Drugs Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024
Report Type : Global

Share This On

Home > Reports > Pharmaceuticals > Healthcare > Global Immunotherapy Drugs Market – Size, Outlook, Trends and Forecast (2024 – 2032)
CHAPTER 1. INTRODUCTION

    1.1. Market Definition

    1.2. Executive Summary

    1.3. The Scope of the Study

CHAPTER 2. RESEARCH METHODOLOGY

    2.1. Secondary Research

    2.2. Primary Research

    2.3. Analytic Tools and Model

    2.4. Economic Indicator

            2.4.1 Base Year, Base Currency, Forecasting Period

    2.5. Expert Validation

    2.6. Study Timeline

CHAPTER 3. MARKET ANALYSIS

    3.1. Industry Value Chain Analysis

    3.2. Porter's Five Force Analysis

            3.2.1. Bargaining Power of Buyers

            3.2.2. Bargaining Power of Suppliers

            3.2.3. Threats of Substitutes

            3.2.4. Threats of New Entrants

            3.2.5. Degree of Competition

    3.3. PESTLE Analysis

            3.3.1. Political

            3.3.2. Economical

            3.3.3. Social

            3.3.4. Technological

            3.3.5. Legal

            3.3.6. Environmental

    3.4. SWOT Analysis

            3.4.1. Strengths

            3.4.2. Weakness

            3.4.3. Opportunities

            3.4.4. Threats

    3.5. Y-O-Y Analysis

CHAPTER 4. MARKET DYNAMICS

    4.1. Market Drivers

            4.1.1. Emergence of Biosimilars

            4.1.2. Increasing prevalence of chronic diseases and lifestyle disorders

            4.1.3. Growing demand for monoclonal antibodies

            4.1.4. The high adoption rate of targeted therapy over traditional therapies

    4.2. Market Restraints & Challenges

            4.2.1. The high cost of immunotherapy treatment

            4.2.2. High reduction rate in the product development cycle

    4.3. Market Opportunities

            4.3.1. Emerging markets

            4.3.2. Immunotherapy to replace chemotherapy in cancer treatment

CHAPTER 5. GLOBAL IMMUNOTHERAPY DRUGS MARKET – BY DRUG TYPE

    5.1. Monoclonal Antibodies

    5.2. Adult Vaccines

            5.2.1. Preventive Vaccines

            5.2.2. Therapeutic Vaccines

    5.3. Checkpoint Inhibitors

    5.4. Interferons Alpha & Beta

    5.5. Interleukins

    5.6. Others

CHAPTER 6. GLOBAL IMMUNOTHERAPY DRUGS MARKET – BY THERAPY 

AREA

    6.1. Cancer

    6.2. Autoimmune and Inflammatory Diseases

    6.3. Infectious Diseases

    6.4. Others

CHAPTER 7. GLOBAL IMMUNOTHERAPY DRUGS MARKET – BY END USER

    7.1. Cancer Research Centers

    7.2. Hospitals/Clinics

    7.3. Others

CHAPTER 8. GLOBAL IMMUNOTHERAPY DRUGS MARKET - BY GEOGRAPHY

    8.1. Introduction

    8.2. North America

            8.2.1. U.S.

            8.2.2. Canada

            8.2.3. Mexico

            8.2.4. Costa Rica

    8.3. South America

            8.3.1. Brazil

            8.3.2. Argentina

            8.3.3. Chile

            8.3.4. Columbia

            8.3.5. Others

    8.4. Europe

            8.4.1. U.K.

            8.4.2. Germany

            8.4.3. France

            8.4.4. Italy

            8.4.5. Spain

            8.4.6. Russia

            8.4.7. Netherlands

            8.4.8. Switzerland

            8.4.9. Poland

            8.4.10. Others

    8.5. APAC

            8.5.1. China

            8.5.2. Japan

            8.5.3. India

            8.5.4. South Korea

            8.5.5. Australia & New Zealand

            8.5.6. Malaysia

            8.5.7. Singapore

            8.5.8. Others

    8.6. Middle East & Africa

            8.6.1. UAE

            8.6.2. Saudi Arabia

            8.6.3. Iran

            8.6.4. Iraq

            8.6.5. Qatar

            8.6.6. South Africa

            8.6.7. Algeria

            8.6.8. Morocco

            8.6.9. Nigeria

            8.6.10. Egypt

            8.6.11. Others

CHAPTER 9. GLOBAL IMMUNOTHERAPY DRUGS MARKET - COMPANY

PROFILES

    9.1. AbbVie Inc.

    9.2. Amgen Inc.

    9.3. AstraZeneca PLC

    9.4. Bristol-Myers Squibb

    9.5. F-Hoffman-La Roche AG

    9.6. Johnson & Johnson

    9.7. Novartis International AG

    9.8. GlaxoSmithKline PLC

    9.9. UbiVac

    9.10. Eli Lilly and Company

    9.11. Merck & Co., Inc.

    9.12. Alligator Bioscience

    9.13. Incyte Corporation

    9.14. Celldex Therapeutics

    9.15. Intrexon Corporation

CHAPTER 10. GLOBAL IMMUNOTHERAPY DRUGS MARKET - COMPETITIVE

LANDSCAPE

    10.1. Market Share Analysis

    10.2. Strategies adopted by top companies

    10.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 11. MARKET INSIGHTS

    11.1. Industry Experts Insights

    11.2. Analysts Opinions

    11.3. Investment Opportunities

CHAPTER 12. APPENDIX

    12.1. List of Tables

    12.2. List of Figures

Other Reports

Global Sesame Seeds Market – Size, Outlook, Trends and...

Starting from $2700

Global Meat Ingredients Market – Growth, Trends And...

Starting from $2700

Unmanned Aerial Vehicle Drones Market – Size, Outlook,...

Starting from $2700

Stay in the loop

Keep up-to-date with our weekly newsletter, Media Pulse.

Data-driven market insights & solutions

Follow Us On

We Accept

Our Office

30 N Gould St Ste N Sheridan,
WY 82801

© 2025 - Envision Intelligence | All Rights Reserved.
Designed by Webixion